I do not have any evidence for my guess. But, based on what we saw in the EIND, I think we are going to be 50-60% effective in reducing mortality. Higher, if we are able to be used earlier in the process and if we are ultimately able to provide additional doses when necessary.

With that said, it is entirely possible that its less, or more. We really dont have enough data to make a competent guess.